Math Suresh Bada, Manjunatha Narayana, Kumar Channaveerachari Naveen, Gowda Guru S, Philip Sharad, Enara Arun, Gowda Mahesh
Department of Psychiatry, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru, Karnataka, India.
Department of Psychiatry, Spandana Health Care, Bengaluru, Karnataka, India.
Indian J Psychiatry. 2019 Apr;61(Suppl 4):S786-S790. doi: 10.4103/psychiatry.IndianJPsychiatry_89_19.
In India, manufacturing, storing, transportation, distribution, and dispensing of drugs are licensed and regulated under the drugs and cosmetic act, 1940; Indian Medical Council Act, 1956; the Pharmacy Act, 1948; and the Narcotic Drugs and Psychotropic Substances Act, 1985. Prescribing and dispensing medicines at the same time to their patients by registered medical practitioners (RMPs) is a well-known practice in all systems of medicine across the country. Further, the kind of branded medicines a patient gets from the clinics will come wrapped in a huge profit margin for RMPs, and this has been an alternative source of income to them. Dispensing and selling of medicines by RMPs at their clinics to their patients may represent a significant potential conflict of interest with the medical ethical principles, namely autonomy, beneficence, and non-maleficence and it raises various ethical and legal challenges. This article focuses on the ethical and legal issues of this practice and emphasizes the need for a proactive and dynamic approach to meet the rising demand for quality healthcare in India.
在印度，药品的制造、储存、运输、分销和配发需根据1940年《药品和化妆品法案》、1956年《印度医学委员会法案》、1948年《药房法案》以及1985年《麻醉药品和精神药物法案》获得许可并受到监管。在该国所有医学体系中，注册医生（RMPs）同时为患者开处方和配发药品是一种普遍做法。此外，患者从诊所获得的品牌药品会给注册医生带来巨大的利润空间，这已成为他们的一种额外收入来源。注册医生在其诊所为患者配发和销售药品可能与医学伦理原则，即自主、行善和不伤害原则存在重大潜在利益冲突，并且引发了各种伦理和法律挑战。本文聚焦于这种做法的伦理和法律问题，并强调需要采取积极主动和动态的方法来满足印度对优质医疗保健不断增长的需求。
